Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 23

1.

Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis.

Bullok KE, Maxwell D, Kesarwala AH, Gammon S, Prior JL, Snow M, Stanley S, Piwnica-Worms D.

Biochemistry. 2007 Apr 3;46(13):4055-65. Epub 2007 Mar 10.

PMID:
17348687
2.

Permeation peptide conjugates for in vivo molecular imaging applications.

Bullok KE, Gammon ST, Violini S, Prantner AM, Villalobos VM, Sharma V, Piwnica-Worms D.

Mol Imaging. 2006 Jan-Mar;5(1):1-15. Review.

PMID:
16779965
3.
4.

Caspase-independent cell death.

Kroemer G, Martin SJ.

Nat Med. 2005 Jul;11(7):725-30. Review.

PMID:
16015365
5.

Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.

Wadia JS, Dowdy SF.

Adv Drug Deliv Rev. 2005 Feb 28;57(4):579-96. Epub 2004 Dec 19. Review.

PMID:
15722165
6.

Apoptosis in the development and treatment of cancer.

Gerl R, Vaux DL.

Carcinogenesis. 2005 Feb;26(2):263-70. Epub 2004 Sep 16. Review.

PMID:
15375012
7.

Pathways of apoptotic and non-apoptotic death in tumour cells.

Okada H, Mak TW.

Nat Rev Cancer. 2004 Aug;4(8):592-603. Review. No abstract available.

PMID:
15286739
8.

Radiolabeled annexin-V for monitoring treatment response in oncology.

Van de Wiele C, Vermeersch H, Loose D, Signore A, Mertens N, Dierckx R.

Cancer Biother Radiopharm. 2004 Apr;19(2):189-94. Review.

PMID:
15186599
9.

Role of molecular imaging in defining and denying death...

Narula J, Kietselaer B, Hofstra L.

J Nucl Cardiol. 2004 May-Jun;11(3):349-57. Review. No abstract available.

PMID:
15173781
10.

Apoptin/VP3 contains a concentration-dependent nuclear localization signal (NLS), not a tumorigenic selective NLS.

Wadia JS, Wagner MV, Ezhevsky SA, Dowdy SF.

J Virol. 2004 Jun;78(11):6077-8. No abstract available.

11.

Apoptosis-detecting radioligands: current state of the art and future perspectives.

Lahorte CM, Vanderheyden JL, Steinmetz N, Van de Wiele C, Dierckx RA, Slegers G.

Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):887-919. Epub 2004 May 12. Review.

PMID:
15138718
12.

Recent advances in the imaging of programmed cell death.

Blankenberg FG.

Curr Pharm Des. 2004;10(13):1457-67. Review.

PMID:
15134569
13.

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

Wadia JS, Stan RV, Dowdy SF.

Nat Med. 2004 Mar;10(3):310-5. Epub 2004 Feb 8.

PMID:
14770178
14.

Apoptosis: the complex scenario for a silent cell death.

Böhm I, Schild H.

Mol Imaging Biol. 2003 Jan-Feb;5(1):2-14. Review.

PMID:
14499155
15.

In vivo monitoring of apoptosis.

Brauer M.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):323-31. Review.

PMID:
12657370
16.

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake.

Gammon ST, Villalobos VM, Prior JL, Sharma V, Piwnica-Worms D.

Bioconjug Chem. 2003 Mar-Apr;14(2):368-76.

PMID:
12643747
17.

Structure and zymogen activation of caspases.

Donepudi M, Grütter MG.

Biophys Chem. 2002 Dec 10;101-102:145-53. Review.

PMID:
12487996
18.

Improved fluoroimmunoassays using the dye Alexa Fluor 647 with the RAPTOR, a fiber optic biosensor.

Anderson GP, Nerurkar NL.

J Immunol Methods. 2002 Dec 20;271(1-2):17-24.

PMID:
12445725
19.

Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy.

Bullok KE, Dyszlewski M, Prior JL, Pica CM, Sharma V, Piwnica-Worms D.

Bioconjug Chem. 2002 Nov-Dec;13(6):1226-37.

PMID:
12440857
20.

Molecular imaging of gene expression and protein function in vivo with PET and SPECT.

Sharma V, Luker GD, Piwnica-Worms D.

J Magn Reson Imaging. 2002 Oct;16(4):336-51. Review.

PMID:
12353250

Supplemental Content

Support Center